Patents-Review.com
ClassID:

114246 ⎘

C12Y114/11027 - CPC Classification

Classification description:

Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11) [Histone H3]-lysine-36 demethylase (1.14.11.27)

Recent Application in this class:
#1
20240390518
2024-11-28

INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF

 #2
20240123086
2024-04-18

INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF

 #3
20220220171
2022-07-14

CELL PERMEABLE PROTEINS FOR GENOME ENGINEERING

 #4
20220056422
2022-02-24

APPLICATION OF UTX GENE IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING LIPID DISEASES

 #5
20210292793
2021-09-23

COMPOSITIONS AND METHODS FOR GENERATING PHYSIOLOGICAL X CHROMOSOME INACTIVATION

 #6
20210238161
2021-08-05

Histone demethylase inhibitors

 #7
20200181648
2020-06-11

METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC

 #8
20200157077
2020-05-21

Histone demethylase inhibitors

 #9
20180319769
2018-11-08

Histone demethylase inhibitors

 #10
20180291400
2018-10-11

METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC

 #11
20180087118
2018-03-29

Method for identifying compound for inhibiting an activity of a histone lysine demethylase

 #12
20170183325
2017-06-29

Histone demethylase inhibitors

 #13
20160025745
2016-01-28

METHODS OF DIAGNOSING AND TREATING FIBROSIS

 #14
20150267241
2015-09-24

Method for identifying compound for inhibiting an activity of a histone lysine demethylase

 #15
20150133564
2015-05-14

Compound, preparing method thereof, and use thereof as inhibitors of histone demethylase

 #16
20110286990
2011-11-24

Methods of diagnosing and treating fibrosis